Viruses (Mar 2024)

Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models

  • Ian Padykula,
  • Lambodhar Damodaran,
  • Kelsey T. Young,
  • Madelyn Krunkosky,
  • Emily F. Griffin,
  • James F. North,
  • Peter J. Neasham,
  • Vasilis C. Pliasas,
  • Chris L. Siepker,
  • James B. Stanton,
  • Elizabeth W. Howerth,
  • Justin Bahl,
  • Constantinos S. Kyriakis,
  • Stephen Mark Tompkins

DOI
https://doi.org/10.3390/v16040548
Journal volume & issue
Vol. 16, no. 4
p. 548

Abstract

Read online

Swine influenza A viruses pose a public health concern as novel and circulating strains occasionally spill over into human hosts, with the potential to cause disease. Crucial to preempting these events is the use of a threat assessment framework for human populations. However, established guidelines do not specify which animal models or in vitro substrates should be used. We completed an assessment of a contemporary swine influenza isolate, A/swine/GA/A27480/2019 (H1N2), using animal models and human cell substrates. Infection studies in vivo revealed high replicative ability and a pathogenic phenotype in the swine host, with replication corresponding to a complementary study performed in swine primary respiratory epithelial cells. However, replication was limited in human primary cell substrates. This contrasted with our findings in the Calu-3 cell line, which demonstrated a replication profile on par with the 2009 pandemic H1N1 virus. These data suggest that the selection of models is important for meaningful risk assessment.

Keywords